Accuray | ARAY - Sales Revenues

Stock Price
0.54
Daily Change
-0.02 -3.08%
Monthly
-33.90%
Yearly
-74.63%
Q1 Forecast
0.52

Accuray reported $116.17M in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 72M 841K Feb/2025
Artivion USD 95.78M 2.24M Sep/2024
AtriCure USD 140.5M 6.2M Dec/2025
Boston Scientific USD 5.29B 220M Dec/2025
Edwards Lifesciences USD 1.57B 20M Dec/2025
Hologic USD 1.05B 0 Dec/2025
Inogen USD 74.93M 504K Sep/2024
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Orthofix International USD 799.49M 602.88M Dec/2024
Surmodics USD 29.92M 96.16M Dec/2024
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Trinity Biotech USD 14.31M 1.55M Sep/2025